Get the Stockscreener App
12.21
1.61%
-0.20
After Hours:
12.41
0.20
+1.64%
Septerna Inc stock is traded at $12.21, with a volume of 225.04K.
It is down -1.61% in the last 24 hours and up +15.19% over the past month.
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
See More
Previous Close:
$12.41
Open:
$12.25
24h Volume:
225.04K
Relative Volume:
0.22
Market Cap:
$544.06M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-12.03%
1M Performance:
+15.19%
6M Performance:
-27.79%
1Y Performance:
+0.00%
1-Day Range:
$11.80
$12.29
1-Week Range:
$11.80
$14.21
52-Week Range:
$4.17
$28.99
Septerna Inc Stock (SEPN) Company Profile
Name
Septerna Inc
Sector
Industry
Phone
650-338-3533
Address
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Compare SEPN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
12.21 | 552.97M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-25 | Initiated | H.C. Wainwright | Buy |
| Feb-18-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-19-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-19-24 | Initiated | JP Morgan | Overweight |
| Nov-19-24 | Initiated | TD Cowen | Buy |
| Nov-19-24 | Initiated | Wells Fargo | Overweight |
View All
Septerna Inc Stock (SEPN) Latest News
What are analysts’ price targets for Septerna Inc. in the next 12 monthsRetirement Planning Report With Low Risk - jammulinksnews.com
How volatile is Septerna Inc. stock compared to the marketAdvanced Screener Data Feed To Watch Now - jammulinksnews.com
Why is Septerna Inc. stock attracting strong analyst attentionSmart Portfolio Growth Plan For Beginners - jammulinksnews.com
Septerna Inc. stock momentum explainedHigh Conviction Intraday Stock Signals Detected - metal.it
Why Septerna Inc. stock attracts strong analyst attentionEntry Alert Based on Volume Spikes Detected - metal.it
Short Interest Drops in Septerna Inc. After RallyWeekly Top Gainers Forecast Watchlist Released - metal.it
What makes Septerna Inc. stock price move sharplySecure Return Focused Investment Plan Released - metal.it
Septerna Inc. Trading Near Value Zone — Recovery AheadMomentum Based Equity Trading Plans Reviewed - metal.it
What is the dividend policy of Septerna Inc. stockDiscover high-impact stocks for growth - jammulinksnews.com
What catalysts could drive Septerna Inc. stock higher in 2025Free Stock Signals For Fast Growth - jammulinksnews.com
What are the technical indicators suggesting about Septerna Inc.Achieve breakthrough profits with expert advice - jammulinksnews.com
Is it the right time to buy Septerna Inc. stockExponential return rates - jammulinksnews.com
What markets is Septerna Inc. expanding into Is BACQ stock a good long term investment optionFree Smart Trading Workshop - jammulinksnews.com
What markets is MUFG expanding into Is Septerna Inc. stock a good long term investment optionAchieve rapid portfolio appreciation - jammulinksnews.com
What are the latest earnings results for Septerna Inc.Achieve rapid portfolio appreciation today - jammulinksnews.com
How high can Septerna Inc. stock price go in 2025Free Stock Market Real-Time Monitoring - jammulinksnews.com
What analysts say about Septerna Inc. stockTremendous growth opportunities - PrintWeekIndia
What drives Septerna Inc. stock priceStrong return on investment - PrintWeekIndia
We Think Septerna (NASDAQ:SEPN) Can Easily Afford To Drive Business Growth - 富途牛牛
Is Septerna Inc. a good long term investmentMassive portfolio appreciation - jammulinksnews.com
Septerna Inc. Stock Analysis and ForecastFree Daily Trading Room Entry - jammulinksnews.com
Septerna Insiders Enjoying US$951k Appreciation On US$934.3k Investment - simplywall.st
Septerna Inc Stock (SEPN) Financials Data
There is no financial data for Septerna Inc (SEPN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Septerna Inc Stock (SEPN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Finer Jeffrey | CEO and President |
Apr 03 '25 |
Option Exercise |
2.76 |
5,000 |
13,800 |
826,907 |
| Ezekowitz Alan | Director |
Mar 07 '25 |
Buy |
6.93 |
13,319 |
92,270 |
117,420 |
| Ezekowitz Alan | Director |
Mar 06 '25 |
Buy |
6.00 |
41,355 |
248,130 |
104,101 |
| Ezekowitz Alan | Director |
Mar 05 '25 |
Buy |
5.82 |
37,835 |
220,260 |
62,746 |
| Ezekowitz Alan | Director |
Mar 04 '25 |
Buy |
6.35 |
7,491 |
47,544 |
24,911 |
| Finer Jeffrey | CEO and President |
Feb 25 '25 |
Buy |
5.68 |
10,000 |
56,765 |
764,907 |
| Finer Jeffrey | CEO and President |
Feb 26 '25 |
Buy |
5.70 |
4,000 |
22,796 |
768,907 |
| Finer Jeffrey | CEO and President |
Feb 27 '25 |
Buy |
5.80 |
3,000 |
17,400 |
771,907 |
| Labrucherie Gil M | Chief Financial Officer |
Feb 25 '25 |
Buy |
5.59 |
6,282 |
35,116 |
36,282 |
| Labrucherie Gil M | Chief Financial Officer |
Feb 27 '25 |
Buy |
5.85 |
3,718 |
21,750 |
40,000 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):